10-K Filing

Silo Pharma, Inc. CIK: 1514183 FY 2012

Filing Information

Form Type	10-K
Accession Number	`0001213900-13-000946`
Period End Date	20121231
Filing Date	20130305
Fiscal Year	2012
Fiscal Period	FY
XBRL Instance	gldsw-20121231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 49 Income Statement 13 Cash Flow Statement 39 Stockholders Equity 16

Balance Sheet 49 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash	`Cash`	$279.00	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash	`Cash`	$1.75K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$279.00	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.75K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Assets	`Assets`	$1.75K	USD	Point-in-time
Total Assets	`Assets`	$279.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.63M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.63M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.63M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.50K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.63M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$20.69K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$5.00K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	-	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$25.69K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$3.50K	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	-	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	$15.00K	USD	Point-in-time
Interest Payable	`InterestPayableCurrentAndNoncurrent`	-	USD	Point-in-time
Interest Payable	`InterestPayableCurrentAndNoncurrent`	$782.00	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$15.78K	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.50K	USD	Point-in-time
Total Liabilities	`Liabilities`	$41.47K	USD	Point-in-time
Preferred stock, $0.0001 par value, 5,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 5,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 30,631,200 shares issued and outstanding	`CommonStockValue`	$3.06K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 30,631,200 shares issued and outstanding	`CommonStockValue`	$3.06K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.12M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.12M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.13M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.17M	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquity`	$47.48K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Total Liabilities and Stockholders' Deficit	`LiabilitiesAndStockholdersEquity`	$1.75K	USD	Point-in-time
Total Liabilities and Stockholders' Deficit	`LiabilitiesAndStockholdersEquity`	$279.00	USD	Point-in-time

Income Statement 13 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	$49.80K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$39.45K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.17M	USD	10 Qtrs
Net loss	`NetIncomeLoss`	$-1.17M	USD	10 Qtrs
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	10 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	Annual
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.45M	shares	10 Qtrs
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	Annual
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	Annual

Cash Flow Statement 39 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.17M	USD	10 Qtrs
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Stock issued for services - related parties	`ShareBasedCompensation`	-	USD	Annual
Stock issued for services - related parties	`ShareBasedCompensation`	-	USD	Annual
Stock issued for services - related parties	`ShareBasedCompensation`	$1.07M	USD	10 Qtrs
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableTrade`	$21.47K	USD	10 Qtrs
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableTrade`	$3.50K	USD	Annual
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableTrade`	$17.97K	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-71.28K	USD	10 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-46.30K	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.47K	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	$20.00K	USD	10 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	$20.00K	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$575.00	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$51.56K	USD	10 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$71.56K	USD	10 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$20.00K	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$575.00	USD	Annual
Net Increase (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$279.00	USD	10 Qtrs
Net Increase (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.47K	USD	Annual
Net Increase (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-45.73K	USD	Annual
Cash - Beginning of Year/Period	`CashAndCashEquivalentsAtCarryingValue`	$47.48K	USD	Point-in-time
Cash - Beginning of Year/Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash - Beginning of Year/Period	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Cash - Beginning of Year/Period	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Cash - End of Year/Period	`CashAndCashEquivalentsAtCarryingValue`	$47.48K	USD	Point-in-time
Cash - End of Year/Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash - End of Year/Period	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Cash - End of Year/Period	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Income Taxes	`IncomeTaxesPaid`	-	USD	Annual
Income Taxes	`IncomeTaxesPaid`	-	USD	10 Qtrs
Income Taxes	`IncomeTaxesPaid`	-	USD	Annual
Interest	`InterestPaid`	-	USD	Annual
Interest	`InterestPaid`	-	USD	Annual
Interest	`InterestPaid`	-	USD	10 Qtrs

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Stock issued for services - related parties, Value per share	`StockIssuedForServicesRelatedPartiesFairMarketValue`	$0.05	USD	2 Qtrs
Stock issued for cash, Minimum fair market value	`StockIssuedForCashMinimumFairMarketValue`	$0.01	USD	2 Qtrs
Stock issued for cash, Maximum fair market value	`StockIssuedForCashMaximumFairMarketValue`	$0.05	USD	2 Qtrs
Beginning Balance	`StockholdersEquity`	$47.48K	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Stock issued for services - related parties ($0.05/share)	`StockIssuedDuringPeriodValueIssuedForServices`	$1.07M	USD	2 Qtrs
Stock issued for cash ($0.005 - $0.05/share)	`StockIssuedDuringPeriodValueIssuedForCash`	$50.98K	USD	2 Qtrs
Receipt of subscription receivable	`StockholdersEquityOther`	$575.00	USD	Annual
Net loss	`NetIncomeLoss`	$-1.17M	USD	10 Qtrs
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Balance	`StockholdersEquity`	$47.48K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Balance	`StockholdersEquity`	$-41.19K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.